Mirum Pharmaceuticals, Inc. (MIRM) Financials
MIRM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 646.6 million | 398.0 million |
2023-09-30 | 650.6 million | 381.6 million |
2023-06-30 | 443.6 million | 365.0 million |
2023-03-31 | 333.5 million | 192.4 million |
MIRM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -21.6 million | 9.7 million |
2023-09-30 | -18.2 million | 8.4 million |
2023-06-30 | -17.4 million | 8.4 million |
2023-03-31 | -33.8 million | 8.6 million |
MIRM Net Income
No data available :(
MIRM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 286.3 million | - | 1.7 million |
2023-09-30 | 306.0 million | - | 2.0 million |
2023-06-30 | 330.0 million | 305.6 million | 2.2 million |
2023-03-31 | 132.1 million | - | 2.0 million |
MIRM Shares Outstanding
MIRM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 5.0 million | 30.8 million | 39.9 million | 6.3 million |
2023-09-30 | - | 26.1 million | 36.5 million | - |
2023-06-30 | 15.1 million | 22.0 million | 32.9 million | - |
2023-03-31 | 41000 | 23.5 million | 30.2 million | - |
MIRM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 69.6 million | 22.6 million |
2023-09-30 | 47.7 million | 10.2 million |
2023-06-30 | 37.5 million | 6.8 million |
2023-03-31 | 31.6 million | 5.0 million |
MIRM
Price: $25.84
52 week price:
Earnings Per Share: -4.00 USD
P/E Ratio: -6.72
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 266732
Market Capitalization: 1.2 billion